The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients

PURPOSE: Tacrolimus (Tac) and cyclosporine (CsA) are mainly metabolized by CYP3A4 and CYP3A5. Several studies have demonstrated an association between the CYP3A5 genotype and Tac dose requirements. Recently, CYP3A4, PPARA, and POR gene variants have been shown to influence CYP3A metabolism. The pres...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lunde, Ingrid, Bremer, Sara, Midtvedt, Karsten, Mohebi, Beata, Dahl, Miriam, Bergan, Stein, Åsberg, Anders, Christensen, Hege
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2014
Gaiak:
Pharmacogenetics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4025175/
https://ncbi.nlm.nih.gov/pubmed/24658827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-014-1656-3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak